IGF-II down regulation associated cell cycle arrest in colon cancer cells exposed to phenolic antioxidant ellagic acid

Anticancer Research

Volumn 21, Issue 1 A, 2001, Pages 359-364

  Narayanan, B A ^a   Re, G G ^a  

^a Division of Pathology and Toxicology   (United States)

Author keywords

Cyclin kinase inhibitor; Ellagic acid; Insulin like growth factor (IGF II); Phenolic antioxidant

Indexed keywords

ANTIOXIDANT; CYCLIN DEPENDENT KINASE INHIBITOR; DNA FRAGMENT; ELLAGIC ACID; MESSENGER RNA; NATURAL PRODUCT; PROTEIN P21; PROTEIN P53; SOMATOMEDIN B;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; COLON CANCER; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIOXIDANTS; APOPTOSIS; CELL CYCLE; CELL DIVISION; CELL NUCLEUS; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA FRAGMENTATION; DNA, NEOPLASM; DOWN-REGULATION; ELLAGIC ACID; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR II; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035059765     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Insulin-like growth factor II prevents apoptosis in a human teratoma-derived cell line
2. Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histological category of Wilms' tumor
3. Detection of type 1 insulin-like growth factor (IGF) receptors in Wilms' tumors
4. Loss of imprinting in hepatoblastoma
5. Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma
6. Loss of imprinting of IGF-II in Ewing£s sarcoma
7. P53 regulates human insulin like growth factor II gene expression through active P4 promotor in rhabdomyosarcoma cells
8. WAF1, a potential mediator of p53 tumor suppression
9. Induction of WAF1/CIP1 by a p53-independent pathway
10. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair
11. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis
12. P53 function and dysfunction
13. Participation of p53 protein in the cellular response to DNA damage
14. p21(Waf1/Cip1) expression is a prognostic factor in patients with p53-negative gastric cancer
15. Prognostic impact of p21/waf1/cip1 in colorectal cancer
16. The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells
17. The p21 cdk-interacting protein Cip1 is a potent inhibitor of C1 cyclin-dependent kinases
18. p21 is a universal inhibitor of cyclin kinases
19. Detection and determination of ellagitannins
20. Antitumor promoting activities of tannin acid, ellagic acid and several gallic acid derivatives in mouse skin
21. Isothiocyanates and plant polyphenols as inhibitors of lung and esophageal cancer
22. Identification of tricyclic analogs related to ellagic acid as potent/selective tyrosine protein kinase inhibitors
23. Structure-function relationships of the dietary anticarcinogen ellagic acid
24. Effect of ellagic acid on hepatic and pulmonary xenobiotic metabolism in mice: Studies on the mechanism of its anticarcinogenic action
25. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes p450 and Phase II enzymes
26. Single-step method of RNA isolation and acid guanidinium thiocyanate-phenolchloroform extraction
27. Modulation of a constitutive transcriptional block at exon-1 controls human c-myc expression
28. p53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells
29. Transcriptional regulation of the p21 (Waf11/Cip1) Gene
30. P53 dependent and independent expression of p21 during cell growth, differentiation and DNA damage
31. CCAAT/enhancer binding protein alpha (C/EBPalpha) inhibits cell proliferation through the p21 (WAF1/CIP1/SDI-1) protein
32. Sp1, but not Sp3 functions to mediate promotor activation by TGF-≤ through canonical Sp1 binding sites
33. C-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines
34. Cell cycle block at G-S or G2-M phase correlates with differentiation of Caco-2 cells: Effects on constitutive insulin-like growth factor II expression
35. The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice
36. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor